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In his letter1 on our recent commentary,2 Dan Eisenberg
argues that Southern blot (SB) and quantitative polymerase
chain reaction (qPCR)-based methods have similar reliabil-
ity of leukocyte telomere length (LTL) measurement, a sug-
gestion that runs counter to the literature going back more
than a decade. This literature shows that the SB-based
method better captures associations of LTL with a host of
variables than does the qPCR-based method. For example,
a recent meta-analysis3 concluded that the influence of sex
on LTL was apparent when using SB, but absent when
using qPCR, and we see a difference in measurement reli-
ability as the most parsimonious explanation for this find-
ing. We consider this meta-analysis important because it
compares how these two methods perform in actual epi-
demiological studies. Such a comparison cannot be derived
from the results achieved in small samples designed to
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assess reliability in laboratory settings (a point elaborated
later). Likewise, with respect to LTL dynamics (LTL and
its age-dependent change), lower reliability is also the most
likely explanation we can see for the much larger propor-
tions of individuals with counter-intuitive elongation of
LTL as they age (i.e. at the second measurement time
point) in qPCR-based than in SB- based studies.4 More-
over, lower reliability primarily explains the difficulties in
detecting the longer LTL in African Americans than in
Whites of European ancestry when using the qPCR-based
method.5 Thus, the epidemiological telomere literature
strongly suggests higher reliability of SB compared with
qPCR.
That said, we welcome Dan Eisenberg’s letter since it
provides a forum to further address highly relevant
issues related to LTL measurements by the SB-based
method, which measures LTL in kilo-bases (kb),6 and
the qPCR-based method, which measures telomere DNA
content as the ratio of telomeric PCR product to single copy
gene PCR product (T/S).7,8 Below we respond
to Eisenberg’s points on: (i) the coefficient of variation
(CV) as a tool to compare measurement reliability be-
tween LTL data generated by SB versus by qPCR; and (ii)
the need for external validation of LTL measured by the
two methods. We also address other validity-related
matters.
The coefficient of variation
In our commentary2 we suggested that it is not appropriate
to use the CV to measure reliability for qPCR, nor to use
the CV to compare reliability of qPCR and SB. We pointed
out that the heteroscedasticity assumption of the CV does
not hold for qPCR measurements. This reason alone is suf-
ficient to require an alternative method to quantify and
compare measurement reliability, for which we proposed
considering the intraclass correlation coefficient (ICC), a
well-established method in other research fields.9
However, Eisenberg makes the additional compelling
point that when using the CV to compare two methods,
one assumes that both measures have the same ‘natural
zero points’. He goes on to argue that this assumption does
not hold for SB, because the terminal restriction fragments
(TRFs) include sub-telomeric regions, and we agree. In
making this assertion about the dependence of CV on
equal zero points, Eisenberg also makes incorrect asser-
tions, and these are unfortunately conflated because they
are illustrated together in his Table 1.1 He suggests that the
higher CVs reported for the qPCR than the SB are entirely
due to the different measurement scales used. To equate
the two measurement scales, he (i) converted T/S from a
ratio to an absolute measure of LTL, and (ii) estimated the
sub-telomeric length, which is included in the terminal re-
striction fragments that are measured by the SB. Both of
these procedures are fraught with problems and we believe
that his conversions are erroneous. Moreover, Eisenberg’s
assertion that qPCR-based TL measurements have a nat-
ural zero point may not generally be correct, due to the
way it is calculated. We discuss these issues in the Supple-
mentary material (available as Supplementary data at IJE
online) as it would require us to digress from the main
points by including details and complexities that many
readers may not find germane.
External validation of LTL measured by the
two methods
Validity of measurement depends upon measurement reli-
ability, but reliable measurement does not ensure validity.
Eisenberg suggests, therefore, a way to gauge the validity
of LTL measures. He proposes that ‘well established cor-
relates of LTL can be utilized as markers of external valid-
ity’. We agree that when LTL is measured by multiple
methods that differ only in random measurement error (re-
liability), one does generally expect stronger and more
valid correlations for the more reliable method with ‘well-
established correlates’. Nevertheless, we do not think that
his proposal, a comparison of reported correlations, should
serve to assess either validity or reliability. First, Eisen-
berg’s approach cannot be used to assess validity because
both methods could be biased; an independent benchmark
Figure 1. Estimated correlations r and 95% confidence intervals (Y axis)
depending on the true value of the correlation being estimated (X axis)
for different levels of measurement reliability (ICC values 0.5, 0.75 and
1). The estimates of r deviate more from the true value when the ICC is
lower. Increasing sample size (50, 100 or 200) decreases the confidence
interval of the estimate, but does not affect the average point estimate.
Note that confidence intervals are large relative to the effect of the ICC
differences on the r estimates, and hence comparing correlation coeffi-
cients will have low statistical power to detect effects of measurement
reliability on r. Note further that correlations in epidemiological telo-
mere studies will reach values as high as the upper limit (0.7) in this ex-
ample only in exceptional circumstances.
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criterion is needed to gauge validity. We do not yet have
such a benchmark. Thus, one correlation may be stronger
than another, but how much closer the best correlation is
to the (unknown) benchmark value remains unknown. Sec-
ond, Eisenberg’s approach is in practice not informative
with respect to measurement reliability. Typically, the sam-
ple sizes in studies that compared different methods to
measure TL are too small to detect relevant differences in
measurement reliability using this approach.
We illustrate this concept in Figure 1, where it can be seen
that even very large differences in measurement reliability are
difficult to detect with sample sizes of 50-200. Thus, the esti-
mates that Eisenberg reports for TL associations with age for
sample sizes of 50-190 (Table 2 in his letter)1 may be viewed
as random samples from the broad distributions in our Figure
1 (albeit they are not entirely independent because they are
based on the same set of samples within each study). Differen-
ces in the distribution of age (frequently non-normal) will
also skew correlations between studies, also arguing against
the use of age as a comparative measure for validity between
studies. Due to the limited sample sizes, possible differences
in age distribution between studies and consequently large
sampling variation, we attribute little value to these point esti-
mates or Eisenberg’s conclusion that there was on average no
difference between SB- and qPCR-based studies.
Validity-related matters
Eisenberg notes that the qPCR assay is considerably influ-
enced by DNA extraction techniques and sample handling.
In our commentary,2 based on theoretical considerations,13
we also suggested that the integrity of the amplifiable se-
quences by the qPCR might be critical for obtaining accurate
results. This point has recently been confirmed in a study
showing that DNA integrity has a considerable effect on TL
measurements by qPCR.14 The requirement to test DNA in-
tegrity in each sample, which is a routine for SB, is typically
not done in qPCR-based studies of LTL and reduces the
high-throughput advantage of the qPCR-based method.
Finally, there is more to understanding the role of telo-
meres in health and disease than just knowing that telomeres
are longer (or shorter) in one individual versus another.
Consequently, many studies have transformed their qPCR
data, expressed in T/S units, to kb, because the information
in T/S data is limited to relative differences that cannot be
compared between studies. The pitfalls of transforming the
T/S to kb become apparent in Eisenberg’s own work.15 His
transformation of T/S to kb produced an implausible range
of LTL across European populations, i.e. from 5.1 kb in Na-
ples to 18.6 kb in Ghent. In his letter, Eisenberg attributes
this to the high inter-laboratory variation in generating T/S,
which can be considerable according to the paper that was
the subject of our commentary.12 However, if that was the
only reason, the range of variation in LTL resulting from
transforming qPCR measures generated in a single labora-
tory to LTL data should be similar to measures generated by
SB. This is hardly the case, since the range of transformed
qPCR data16 is considerably larger than the range generated
by SB.17,18 A likely explanation is that transforming qPCR
to SB data is based on linear models, whereas the relation
between data generated by qPCR and SB is often curvilinear
(see Supplementary material, available as Supplementary
data at IJE online).
Conclusions
The SB- and the qPCR-based methods of LTL measure-
ments have been important partners in gaining insight into
the role of telomeres in human health and disease. Togeth-
er they have been instrumental, for instance, in deciphering
the LTL-SNPs19–23 that opened the door to remarkable ad-
vances in understanding the role of telomeres in a host of
human diseases. The lower measurement reliability of the
qPCR-based method renders it less suited to studies with
small sample-sizes, but the high throughput of the method
makes it a powerful tool in large epidemiological studies
where increasing sample size can offset higher measure-
ment error. Note, however, that lower measurement reli-
ability and the attendant non-differential misclassification
also attenuates effect size estimates, and the attenuation ef-
fect is independent of sample size (Figure 1). Thus, as we
stated before, we see a role for both methods, depending
on characteristics of the study design. However, in the light
of the epidemiological literature, we consider attempts to
show that the qPCR-based method is equal to the SB
method in reliability to be misleading.
Eisenberg and we agree that the CV is a suboptimal in-
dicator of measurement reliability, supporting the use, for
example, of the ICC to evaluate measurement reliability in
future telomere studies. Notably, the ICC can be calculated
in different ways that provide different information,9 and
it is important therefore to report exactly how the ICC was
calculated. Should inter-assay ICCs or other substitutes for
CV become standard in telomere epidemiology, the data
will be available to make a more quantitative assessment
of the reliability of the different techniques as they are
applied in the field.
Supplementary Data
Supplementary data are available at IJE online.
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